47 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
sale, trust receipt, lien, charge, lien or title retention contract, lease or consignment intended as a security device, or any other security or lien … or title retention contract, lease or consignment of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under
8-K
EX-10.26
xma061g
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.24.1
euje9fzerz
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.1
rkyy0fvl7fu dsf8l
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.5
45nakzv
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.2
3uxizn 0kt5e
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
424B3
89u7bl quastzw6pu8e
22 Sep 23
Prospectus supplement
4:08pm
425
EX-10.2
l7u45v
22 Sep 23
Business combination disclosure
12:55pm
8-K
EX-10.2
ea6d6z
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
424B3
4ya8z8
21 Sep 23
Prospectus supplement
7:31pm
425
EX-10.1
upyoey8wqfl531j
19 Sep 23
Business combination disclosure
3:52pm
8-K
EX-10.1
vc4ot9uhpkqa leh
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm